Review Article
LOX-1, OxLDL, and Atherosclerosis
| Proinflammatory cytokines | | Tumor necrosis factor (TNF) | | Interleukin-1 (IL-1) | | Interferon (IFN) | | Lipopolysaccharide (LPS) | | C-reactive protein (CRP) | | Modified lipoproteins | | OxLDL (copper-oxidized LDL) | | 15-Lipoxygenase-modified LDL | | 15-Lipoxygenase-modified HDL3 | | Glycoxidized-LDL | | Lysophosphatidylcholine (LPC) | | Palmitic acid | | Hypertension-related stimuli | | Angiotensin II | | Endothelin-1 | | Fluid shear stress | | Hyperglycemic stimuli | | High glucose | | Advanced glycation end-products (AGEs) | | Other stimuli | | Homocysteine | | Free radicals | |
|
|